Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Monotherapy for HBV Reinfection Prevention After Liver Transplantation
NCT01046799Phase 3Completed
- Start
- Mar 2008
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of entecavir in hepatitis B (HBV). Primary endpoint: Prevention of hepatitis B virus reinfection at 1 year. Started Mar 2008; status: completed.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01046799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046799.